47 related articles for article (PubMed ID: 10980621)
1. The BRCA2 activation domain associates with and is phosphorylated by a cellular protein kinase.
Milner J; Fuks F; Hughes-Davies L; Kouzarides T
Oncogene; 2000 Sep; 19(38):4441-5. PubMed ID: 10980621
[TBL] [Abstract][Full Text] [Related]
2. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
[TBL] [Abstract][Full Text] [Related]
3. Effector peptides from glutathione-S-transferase-pi affect the activation of jun by jun-N-terminal kinase.
Adler V; Pincus MR
Ann Clin Lab Sci; 2004; 34(1):35-46. PubMed ID: 15038666
[TBL] [Abstract][Full Text] [Related]
4. Differential targeting of the stress mitogen-activated protein kinases to the c-Jun dimerization protein 2.
Katz S; Aronheim A
Biochem J; 2002 Dec; 368(Pt 3):939-45. PubMed ID: 12225289
[TBL] [Abstract][Full Text] [Related]
5. A direct interaction between JNK1 and CrkII is critical for Rac1-induced JNK activation.
Girardin SE; Yaniv M
EMBO J; 2001 Jul; 20(13):3437-46. PubMed ID: 11432831
[TBL] [Abstract][Full Text] [Related]
6. Potential role of BRCA2 in a mitotic checkpoint after phosphorylation by hBUBR1.
Futamura M; Arakawa H; Matsuda K; Katagiri T; Saji S; Miki Y; Nakamura Y
Cancer Res; 2000 Mar; 60(6):1531-5. PubMed ID: 10749118
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of breast and brain cancer cell growth by BCCIPalpha, an evolutionarily conserved nuclear protein that interacts with BRCA2.
Liu J; Yuan Y; Huan J; Shen Z
Oncogene; 2001 Jan; 20(3):336-45. PubMed ID: 11313963
[TBL] [Abstract][Full Text] [Related]
8. Multiple possible sites of BRCA2 interacting with DNA repair protein RAD51.
Katagiri T; Saito H; Shinohara A; Ogawa H; Kamada N; Nakamura Y; Miki Y
Genes Chromosomes Cancer; 1998 Mar; 21(3):217-22. PubMed ID: 9523196
[TBL] [Abstract][Full Text] [Related]
9. BRCA2 associates with acetyltransferase activity when bound to P/CAF.
Fuks F; Milner J; Kouzarides T
Oncogene; 1998 Nov; 17(19):2531-4. PubMed ID: 9824164
[TBL] [Abstract][Full Text] [Related]
10. Catalytic activation of mitogen-activated protein (MAP) kinase phosphatase-1 by binding to p38 MAP kinase: critical role of the p38 C-terminal domain in its negative regulation.
Hutter D; Chen P; Barnes J; Liu Y
Biochem J; 2000 Nov; 352 Pt 1(Pt 1):155-63. PubMed ID: 11062068
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
Grau R; Iñiguez MA; Fresno M
Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
[TBL] [Abstract][Full Text] [Related]
12. Interaction between BRCA2 and replication protein A is compromised by a cancer-predisposing mutation in BRCA2.
Wong JM; Ionescu D; Ingles CJ
Oncogene; 2003 Jan; 22(1):28-33. PubMed ID: 12527904
[TBL] [Abstract][Full Text] [Related]
13. Differential activation of c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinases by methyl methanesulfonate in the liver and brain of rats: implication for organ-specific carcinogenesis.
Suh Y; Kang UG; Kim YS; Kim WH; Park SC; Park JB
Cancer Res; 2000 Sep; 60(18):5067-73. PubMed ID: 11016630
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic effect of delta deletion in v-Jun does not result from uncoupling Jun from JNK signaling.
Sprowles A; Wisdom R
Oncogene; 2003 Jan; 22(4):498-506. PubMed ID: 12555063
[TBL] [Abstract][Full Text] [Related]
15. The BRCA2 transactivation domain does not interact with JNK.
May GH; Harris F; Gillespie D; Black DM
Genes Chromosomes Cancer; 1999 Aug; 25(4):407-9. PubMed ID: 10398438
[TBL] [Abstract][Full Text] [Related]
16. A peptide fragment of ependymin neurotrophic factor uses protein kinase C and the mitogen-activated protein kinase pathway to activate c-Jun N-terminal kinase and a functional AP-1 containing c-Jun and c-Fos proteins in mouse NB2a cells.
Adams DS; Hasson B; Boyer-Boiteau A; El-Khishin A; Shashoua VE
J Neurosci Res; 2003 May; 72(3):405-16. PubMed ID: 12692907
[TBL] [Abstract][Full Text] [Related]
17. A novel splice variant of mouse interleukin-1-receptor-associated kinase-1 (IRAK-1) activates nuclear factor-kappaB (NF-kappaB) and c-Jun N-terminal kinase (JNK).
Yanagisawa K; Tago K; Hayakawa M; Ohki M; Iwahana H; Tominaga S
Biochem J; 2003 Feb; 370(Pt 1):159-66. PubMed ID: 12418963
[TBL] [Abstract][Full Text] [Related]
18. Nuclear localization signals of the BRCA2 protein.
Yano K; Morotomi K; Saito H; Kato M; Matsuo F; Miki Y
Biochem Biophys Res Commun; 2000 Apr; 270(1):171-5. PubMed ID: 10733923
[TBL] [Abstract][Full Text] [Related]
19. Cells deleted for Brca2 COOH terminus exhibit hypersensitivity to gamma-radiation and premature senescence.
Morimatsu M; Donoho G; Hasty P
Cancer Res; 1998 Aug; 58(15):3441-7. PubMed ID: 9699678
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional activation functions in BRCA2.
Milner J; Ponder B; Hughes-Davies L; Seltmann M; Kouzarides T
Nature; 1997 Apr; 386(6627):772-3. PubMed ID: 9126734
[No Abstract] [Full Text] [Related]
[Next] [New Search]
